NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioMind

BioMind

Private
SingaporeHealthcare & Life Scienceshttps://biomind.ai/

Last Round

Series B

Aug 1, 2021

Est. Valuation

$500M

Company Overview

BioMind is a healthtech company that develops artificial intelligence-based medical imaging diagnostic software to assist physicians in identifying and analyzing medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIdiagnostic support softwareAI-assisted diagnosismedical imaging analysissoftware as a medical deviceSaMDradiology AIdeep learningclinical decision supporthealthcare analyticsmedtechdrug discoverygenomic data analysisPACS integrationprecision medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioMind Comparables

Compare BioMind with similar companies based on industry and business-model similarity.

BioMind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qure.ai
81%
Brainomix
81%
GE HealthCare Technologies Inc.
80%

BioMind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 1, 2021
Series A ExtensionNov 1, 2020
Series AAug 1, 2019
AngelNov 1, 2018

BioMind Investors

Notable investors and investment history

BioMind investors
InvestorRounds
Power CapitalSeries A Extension
China Science and Technology Industry Investment ManagementSeries B
Tianfeng Tianrui InvestmentSeries A Extension
Bosera Asset ManagementSeries A Extension
Green Harbor InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    Monthly visitors grew 153% MoM.

BioMind Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioMind Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioMind's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range6
Year Founded2017
Last FundingAug 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.